Meloxicam 1 A Pharma

Meloxicam, the active ingredient in Meloxicam 1 A Pharma, is a nonsteroidal anti-inflammatory drug presented as an oral dosage form for oral use. It is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal conditions.

GNH USA supplies Meloxicam 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam acts on inflammatory pathways and is indicated for several musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and inflammation, improving function. - Rheumatoid arthritis: alleviates swelling and pain, helping preserve joint mobility. - Ankylosing spondylitis: diminishes spinal inflammation and stiffness, enhancing posture. - Acute musculoskeletal pain: provides rapid analgesic and anti‑inflammatory relief.

Meloxicam may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure: mild hypertension. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events: myocardial infarction or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation or liver injury. - Renal impairment: acute kidney injury. - Anaphylaxis: severe allergic reaction.

Before prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk.

- Renal function: assess baseline kidney function and monitor during therapy. - Cardiovascular risk: use cautiously in patients with hypertension, heart failure or prior thrombotic events. - Gastrointestinal risk: avoid in individuals with a history of peptic ulcer disease or GI bleeding. - Pregnancy and lactation: safety not established; avoid unless clearly necessary. - Drug interactions: review concomitant use of other NSAIDs, anticoagulants or antihypertensives. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective COX‑2 inhibitors: heightened cardiovascular risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: increased risk of renal impairment and electrolyte disturbances. - Lithium: meloxicam can raise lithium serum concentrations.